Federation Des Caisses Desjardins Du Quebec Biomarin Pharmaceutical Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 8,589 shares of BMRN stock, worth $572,285. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,589
Previous 7,598 13.04%
Holding current value
$572,285
Previous $625,000 3.52%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$69.02 - $93.84 $68,398 - $92,995
991 Added 13.04%
8,589 $603,000
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $178,483 - $221,143
2,398 Added 46.12%
7,598 $625,000
Q1 2024

May 15, 2024
BUY
$83.81 - $99.0 $435,812 - $514,800
5,200 New
5,200 $458 Million
Q4 2023

Aug 14, 2024
SELL
$76.22 - $98.51 $136,510 - $176,431
-1,791 Reduced 30.15%
4,150 $400 Million
Q3 2023

Aug 14, 2024
SELL
$85.07 - $94.48 $54,359 - $60,372
-639 Reduced 9.71%
5,941 $526 Million
Q2 2023

Aug 14, 2024
SELL
$86.68 - $100.3 $57,988 - $67,100
-669 Reduced 9.23%
6,580 $570 Million
Q1 2023

Aug 14, 2024
BUY
$87.74 - $117.27 $423,784 - $566,414
4,830 Added 199.67%
7,249 $705 Million
Q4 2022

Aug 14, 2024
BUY
$80.93 - $108.63 $24,279 - $32,589
300 Added 14.16%
2,419 $250 Million
Q3 2022

Aug 14, 2024
SELL
$82.16 - $96.94 $15,446 - $18,224
-188 Reduced 8.15%
2,119 $180 Million
Q2 2022

Aug 14, 2024
SELL
$71.48 - $86.85 $5,718 - $6,948
-80 Reduced 3.35%
2,307 $191 Million
Q1 2022

Aug 14, 2024
SELL
$74.28 - $92.69 $387,073 - $483,007
-5,211 Reduced 68.58%
2,387 $184 Million
Q3 2021

Aug 30, 2024
BUY
$74.77 - $85.47 $114,921 - $131,367
1,537 Added 236.46%
2,187 $169 Million
Q2 2021

Aug 30, 2024
SELL
$75.51 - $84.79 $524,643 - $589,120
-6,948 Reduced 91.45%
650 $54.2 Million
Q1 2021

Aug 30, 2024
SELL
$74.73 - $90.69 $3,736 - $4,534
-50 Reduced 2.88%
1,687 $127 Million
Q4 2020

Aug 30, 2024
BUY
$72.61 - $90.2 $71,666 - $89,027
987 Added 131.6%
1,737 $152 Million
Q3 2020

Aug 30, 2024
BUY
$71.87 - $131.03 $28,748 - $52,412
400 Added 114.29%
750 $57.1 Million
Q4 2018

Aug 30, 2024
SELL
$80.14 - $106.07 $580,854 - $768,795
-7,248 Reduced 95.39%
350 $29.8 Million
Q1 2018

Aug 30, 2024
BUY
$77.67 - $92.63 $27,184 - $32,420
350 New
350 $28.4 Million
Q4 2017

Aug 30, 2024
SELL
$80.76 - $95.13 $8,076 - $9,513
-100 Closed
0 $0
Q1 2017

Aug 30, 2024
SELL
N/A
-7,498
100 $8.78 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email